Clinical impact of dose overestimation by effective path length calculation in stereotactic ablative radiation therapy of lung tumors

Practical Radiation Oncology

Volumn 3, Issue 4, 2013, Pages 294-300

  Liu, Michael B ^a   Eclov, Neville C W ^a   Trakul, Nicholas ^a   Murphy, James ^a   Diehn, Maximilian ^a,b   Le, Quynh Thu ^a,b   Dieterich, Sonja ^a,c   Maxim, Peter G ^a,b   Loo, Billy W ^a,b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD CANCER INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CANCER CONTROL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DOSE OVERESTIMATION; DOSE RESPONSE; DOSIMETRY; EFFECTIVE PATH LENGTH CALCULATION; FEMALE; FOLLOW UP; HUMAN; LUNG TUMOR; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL COMPUTING; MONTE CARLO METHOD; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE DISTRIBUTION; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT PLANNING; TUMOR RECURRENCE; TUMOR VOLUME;

EID: 84884354671     PISSN: 18798500     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.prro.2012.09.003     Document Type: Article

References (23)

1. Davidson S.E., Popple R.A., Ibbott G.S., Followill D.S. Technical note: Heterogeneity dose calculation accuracy in IMRT: study of five commercial treatment planning systems using an anthropomorphic thorax phantom. Med Phys 2008, 35:5434-5439.
2. American Association of Physicists in Medicine Report No 85: Tissue inhomogeneity corrections for megavoltage photon beams. Madison, WI; 2004.
3. Lax I., Panettieri V., Wennberg B., et al. Dose distributions in SBRT of lung tumors: comparison between two different treatment planning algorithms and Monte-Carlo simulation including breathing motions. Acta Oncol 2006, 45:978-988.
4. Vanderstraeten B., Reynaert N., Paelinck L., et al. Accuracy of patient dose calculation for lung IMRT: A comparison of Monte Carlo, convolution/superposition, and pencil beam computations. Med Phys 2006, 33:3149-3158.
5. Wilcox E.E., Daskalov G.M. Accuracy of dose measurements and calculations within and beyond heterogeneous tissues for 6 MV photon fields smaller than 4 cm produced by Cyberknife. Med Phys 2008, 35:2259-2266.
6. Deng J., Guerrero T., Ma C.M., Nath R. Modelling 6 MV photon beams of a stereotactic radiosurgery system for Monte Carlo treatment planning. Phys Med Biol 2004, 49:1689-1704.
7. Deng J., Ma C.M., Hai J., Nath R. Commissioning 6 MV photon beams of a stereotactic radiosurgery system for Monte Carlo treatment planning. Med Phys 2003, 30:3124-3134.
8. Fragoso M., Wen N., Kumar S., et al. Dosimetric verification and clinical evaluation of a new commercially available Monte Carlo-based dose algorithm for application in stereotactic body radiation therapy (SBRT) treatment planning. Phys Med Biol 2010, 55:4445-4464.
9. Solberg T.D., DeMarco J.J., Holly F.E., Smathers J.B., DeSalles A.A. Monte Carlo treatment planning for stereotactic radiosurgery. Radiother Oncol 1998, 49:73-84.
10. Chen H., Lohr F., Fritz P., et al. Stereotactic, single-dose irradiation of lung tumors: a comparison of absolute dose and dose distribution between pencil beam and Monte Carlo algorithms based on actual patient CT scans. Int J Radiat Oncol Biol Phys 2010, 78:955-963.
11. Wilcox E.E., Daskalov G.M., Lincoln H. Stereotactic radiosurgery-radiotherapy: should Monte Carlo treatment planning be used for all sites?. Pract Radiat Oncol 2011, 1:251-260.
12. Wilcox E.E., Daskalov G.M., Lincoln H., Shumway R.C., Kaplan B.M., Colasanto J.M. Comparison of planned dose distributions calculated by Monte Carlo and Ray-Trace algorithms for the treatment of lung tumors with cyberknife: a preliminary study in 33 patients. Int J Radiat Oncol Biol Phys 2010, 77:277-284.
13. van der Voort van Zyp N.C., Hoogeman M.S., van de Water S., et al. Clinical introduction of Monte Carlo treatment planning: a different prescription dose for non-small cell lung cancer according to tumor location and size. Radiother Oncol 2010, 96:55-60.
14. Trakul N., Chang C.N., Harris J., et al. Tumor volume-adapted dosing in stereotactic ablative radiotherapy of lung tumors. Int J Radiat Oncol Biol Phys 2012, 84:231-237.
15. Wulf J., Baier K., Mueller G., Flentje M.P. Dose-response in stereotactic irradiation of lung tumors. Radiother Oncol 2005, 77:83-87.
16. Guckenberger M., Wulf J., Mueller G., et al. Dose-response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys 2009, 74:47-54.
17. Xiao Y., Papiez L., Paulus R., et al. Dosimetric evaluation of heterogeneity corrections for RTOG 0236: stereotactic body radiotherapy of inoperable stage I-II non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2009, 73:1235-1242.
18. Aarup L.R., Nahum A.E., Zacharatou C., et al. The effect of different lung densities on the accuracy of various radiotherapy dose calculation methods: implications for tumour coverage. Radiother Oncol 2009, 91:405-414.
19. Knoos T., Wieslander E., Cozzi L., et al. Comparison of dose calculation algorithms for treatment planning in external photon beam therapy for clinical situations. Phys Med Biol 2006, 51:5785-5807.
20. Lagerwaard F.J., Haasbeek C.J., Smit E.F., Slotman B.J., Senan S. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008, 70:685-692.
21. Onishi H., Shirato H., Nagata Y., et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol 2007, 2(7 Suppl 3):S94-S100.
22. Timmerman R., Paulus R., Galvin J., et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010, 303:1070-1076.
23. Chen V.J., Oermann E., Vahdat S., et al. CyberKnife with tumor tracking: an effective treatment for high-risk surgical patients with stage I non-small cell lung cancer. Front Oncol 2012, 2:9.